Permanently Discontinued

SODIUM BICARBONATE INJECTION, USP

FRESENIUS KABI CANADA LTD

This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.

Quick answers

Is SODIUM BICARBONATE INJECTION, USP discontinued in Canada?

Yes. The manufacturer has reported to Health Canada that SODIUM BICARBONATE INJECTION, USP 42MG has been permanently discontinued (last updated October 3, 2024). It is not expected to come back, so talk to your pharmacist or doctor about an alternative.

Why is SODIUM BICARBONATE INJECTION, USP not available?

The reason the manufacturer reported: Business reasons.

Can I still get this?Check with your pharmacist — only products with a different form or route found

StatusPermanently Discontinued

Same-ingredient products on file2 products · 0 same form & route

Affected strength42MG

Report last updated2024-10-03

Checked by MedShort2026-11-12

Other Products Containing the Same Active Ingredient

These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.

Other Products

BICARBONATE CONCENTRATE D17000

VANTIVE ULC

81.3G · DIN 00691623

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

BICARBONATE CONCENTRATE B38

CHIEF MEDICAL SUPPLIES LTD

80.7G · DIN 02248934

Different strengthSame dosage formDifferent routeNo current shortage

Compare these two →

What this means

Does this mean I need to switch medications right away?

Not necessarily right away, but this product will not be returning to the market.

What should I do?

Talk to your pharmacist or prescriber about your options well before your current supply runs out.

⚠ Possible Recall or Safety Alert

Health Canada has issued a recall or safety alert matching this product. This match is based on product name similarity and may not be exact — confirm against your specific lot number before taking action.

EPINEPHRINE INJECTION USP, SODIUM BICARBONATE INJECTION USP & DEXTROSE INJECTION USP

EPINEPHRINE, SODIUM BICARBONATE & DEXTROSE USP INJECTIONS : Possible microbiological contamination.

Type I2025-07-28

Highest health risk

Possible match — not confirmed

Sodium Acetate Injection USP

Sodium Acetate Injection USP; Incorrect GTIN

Type II2025-03-05

Moderate health risk

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP - Potential for the Presence of Particulate Matter

2022-03-15

Possible match — not confirmed

Sodium Acetate Injection, USP

Sodium Acetate Injection, USP: Particulate matter

Type I2022-03-07

Highest health risk

Possible match — not confirmed

DIN

02486628

Strength

42MG

Dosage Form

SOLUTION

Route

INTRAVENOUS

Active Ingredient

SODIUM BICARBONATE

See all SODIUM BICARBONATE products →

Compare with another product →

Product Monograph

Official Product Monograph (Health Canada)

View official Health Canada drug record ↗

Shortage History

2024-10-03

Permanently Discontinued

Business reasons

Other Products from FRESENIUS KABI CANADA LTD

Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.

0.9% SODIUM CHLORIDE INJECTION

900MG · DIN 02395150

2% CALCIUM GLUCONATE IN SODIUM CHLORIDE INJECTION

20MG · DIN 02538644

5% DEXTROSE INJECTION

50MG · DIN 02403536

ACYCLOVIR SODIUM INJECTION

50MG · DIN 02236926

ADDNUTRIV

DIN 02497697

ADENOSINE INJECTION

3MG · DIN 02267659